UBS Group AG - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$20,204,102
-12.3%
744,440
-0.7%
0.01%
-12.5%
Q2 2023$23,047,100
+27.4%
749,743
+49.4%
0.01%
+14.3%
Q1 2023$18,085,438
-37.8%
501,955
-31.7%
0.01%
-36.4%
Q4 2022$29,054,513
+47.0%
735,185
+49.5%
0.01%
+22.2%
Q3 2022$19,764,000
+137.7%
491,861
+148.7%
0.01%
+200.0%
Q2 2022$8,316,000
-55.3%
197,799
-58.6%
0.00%
-50.0%
Q1 2022$18,610,000
+3.5%
477,689
+5.9%
0.01%
+20.0%
Q4 2021$17,977,000
+70.9%
451,110
+54.9%
0.01%
+66.7%
Q3 2021$10,522,000
-68.7%
291,140
-64.5%
0.00%
-72.7%
Q2 2021$33,594,000
+73.3%
819,544
+84.4%
0.01%
+83.3%
Q1 2021$19,390,000
+73.7%
444,533
+99.3%
0.01%
+50.0%
Q4 2020$11,165,000
+395.6%
223,086
+316.6%
0.00%
+300.0%
Q3 2020$2,253,000
+421.5%
53,550
+501.6%
0.00%
Q2 2020$432,0008,9010.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders